Ed Amer, a partner in Goodwin's Private Equity group, represents private equity and venture capital firms, operating companies and investors in a broad range of transactions, including leveraged buyouts, carve-outs, exits, growth equity financings and general corporate representation, with a particular focus on the healthcare and life science industries. Prior to pursuing a career in law, Mr. Amer worked as a lighting technician in the motion picture industry.





Mr. Amer’s recent representations include:


  • Teva Pharmaceuticals in the sale of its Plan B One Stop product and related assets to Foundation Consumer Healthcare.
  • Agilux Laboratories, an Ampersand Capital Partners portfolio company, in its sale to Charles River Laboratories.
  • TA Associates in its acquisition of National Intergovernmental Purchasing Alliance, a group purchasing organization serving public agencies and educational institutions.
  • Confluent Medical in its acquisition of Interface Catheter Solutions, a contract manufacturer of balloon catheter systems.
  • MPI research, an early stage drug development clinical research organization, in its sale to Avista Capital Partners.
  • DigiCert, a leading digital certificate provider, in its majority acquisition by Thoma Bravo.
  • ViraCor-IBT Laboratories, a premier specialty diagnostics laboratory, in its acquisition by Eurofins Scientific.*


  • Brammer Bio, a cell and gene therapy biologics contract development and manufacturing organization, in its acquisition of a biologics manufacturing facility from Biogen.
  • Ampersand Capital Partners and 1315 Capital in their acquisition of Genoptix, an oncology diagnostics company, from Novartis.
  • Avista Pharma in its acquisition of the GMP contract manufacturing, development and animal health services business of Scynexis.

Growth Equity:

  • Ampersand Capital Partners in its acquisition of a majority stake in Corpus Medical, a contract developer and manufacturer of interventional medical devices.
  • Primus Capital Partners in its investment in EnableComp, a healthcare technology company providing workers compensation reimbursement services.
  • Florida Biologix in its merger with Brammer Biopharmaceuticals, forming Brammer Bio, and simultaneous growth equity investment.
  • Ampersand Capital Partners in its minority investment in CutisPharma, an industry leader in prescription compounding pharmaceuticals.*

*Denotes experience prior to joining Goodwin. 


In law school, Mr. Amer served on the Boston College Law Review and was a member of the Order of the Coif.

In The News









J.D., 2004
Boston College Law School

(magna cum laude)

B.A., 1992
Bowdoin College



Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique